Market Closed -
Sao Paulo
04:06:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
2.65
BRL
|
+3.11%
|
|
+3.52%
|
-33.08%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,003
|
4,149
|
1,933
|
2,140
|
1,534
|
-
|
-
|
Enterprise Value (EV)
1 |
5,685
|
4,699
|
3,347
|
2,140
|
2,775
|
2,634
|
2,776
|
P/E ratio
|
35.9
x
|
25.7
x
|
7.56
x
|
396
x
|
34.2
x
|
11.6
x
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.55
x
|
0.51
x
|
0.2
x
|
0.18
x
|
0.13
x
|
0.12
x
|
0.11
x
|
EV / Revenue
|
0.78
x
|
0.58
x
|
0.34
x
|
0.18
x
|
0.24
x
|
0.2
x
|
0.2
x
|
EV / EBITDA
|
9.93
x
|
7
x
|
4.16
x
|
4.5
x
|
4.63
x
|
3.86
x
|
2.91
x
|
EV / FCF
|
-26.1
x
|
-23.3
x
|
-0.72
x
|
-
|
2.35
x
|
-7.28
x
|
5.91
x
|
FCF Yield
|
-3.83%
|
-4.29%
|
-138%
|
-
|
42.6%
|
-13.7%
|
16.9%
|
Price to Book
|
1.78
x
|
2.01
x
|
-
|
-
|
0.54
x
|
-
|
-
|
Nbr of stocks (in thousands)
|
443,781
|
443,780
|
441,412
|
540,449
|
578,913
|
-
|
-
|
Reference price
2 |
9.020
|
9.350
|
4.380
|
3.960
|
2.650
|
2.650
|
2.650
|
Announcement Date
|
3/2/21
|
3/9/22
|
3/7/23
|
3/5/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
6,422
|
7,308
|
8,063
|
9,819
|
11,961
|
11,797
|
13,172
|
13,752
|
EBITDA
1 |
-
|
572.4
|
671
|
804.8
|
476
|
599.5
|
682.5
|
953.3
|
EBIT
1 |
-
|
321.8
|
392.3
|
417.5
|
280.4
|
573.5
|
545.7
|
767
|
Operating Margin
|
-
|
4.4%
|
4.87%
|
4.25%
|
2.34%
|
4.86%
|
4.14%
|
5.58%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
173.3
|
229.2
|
-281.7
|
90
|
222
|
283
|
Net income
1 |
-
|
96
|
164.5
|
263.7
|
2.516
|
70
|
152.5
|
206
|
Net margin
|
-
|
1.31%
|
2.04%
|
2.69%
|
0.02%
|
0.59%
|
1.16%
|
1.5%
|
EPS
2 |
-0.0196
|
0.2515
|
0.3636
|
0.5797
|
0.0100
|
0.0774
|
0.2294
|
-
|
Free Cash Flow
1 |
-
|
-217.6
|
-201.6
|
-4,624
|
-
|
1,182
|
-362
|
470
|
FCF margin
|
-
|
-2.98%
|
-2.5%
|
-47.09%
|
-
|
10.02%
|
-2.75%
|
3.42%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
197.16%
|
-
|
49.3%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
1,688.57%
|
-
|
228.16%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/22/20
|
3/2/21
|
3/9/22
|
3/7/23
|
3/5/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Net sales
1 |
1,912
|
2,075
|
2,112
|
2,210
|
2,653
|
2,843
|
2,813
|
2,837
|
3,082
|
3,062
|
3,086
|
EBITDA
1 |
160.4
|
159
|
162.4
|
132.1
|
101.7
|
232.5
|
168.5
|
271.5
|
143.8
|
124.6
|
88.33
|
EBIT
|
-
|
80.2
|
-
|
131.3
|
-
|
113.7
|
-
|
141.4
|
-
|
-
|
-
|
Operating Margin
|
-
|
3.87%
|
-
|
5.94%
|
-
|
4%
|
-
|
4.98%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
46.4
|
-
|
63.26
|
-
|
-
|
-
|
-
|
-
|
Net income
|
35.6
|
-
|
-
|
53.6
|
-
|
101.9
|
-62.8
|
-
|
-
|
-
|
-
|
Net margin
|
1.86%
|
-
|
-
|
2.42%
|
-
|
3.58%
|
-2.23%
|
-
|
-
|
-
|
-
|
EPS
|
0.0688
|
0.0491
|
0.0491
|
-
|
0.1867
|
0.2948
|
-0.1376
|
-0.0786
|
-0.0500
|
0.2800
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/3/21
|
3/9/22
|
5/2/22
|
8/1/22
|
11/7/22
|
3/7/23
|
5/10/23
|
8/7/23
|
11/6/23
|
3/5/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
1,682
|
549
|
1,414
|
-
|
1,241
|
1,100
|
1,242
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
2.939
x
|
0.8188
x
|
1.757
x
|
-
|
2.07
x
|
1.611
x
|
1.303
x
|
Free Cash Flow
1 |
-
|
-218
|
-202
|
-4,624
|
-
|
1,182
|
-362
|
470
|
ROE (net income / shareholders' equity)
|
-
|
6.47%
|
8.76%
|
6.09%
|
-
|
3.43%
|
6.13%
|
8%
|
ROA (Net income/ Total Assets)
|
-
|
1.82%
|
2.87%
|
1.78%
|
-
|
0.38%
|
1.08%
|
-
|
Assets
1 |
-
|
5,281
|
5,741
|
14,839
|
-
|
18,519
|
14,160
|
-
|
Book Value Per Share
2 |
-
|
5.080
|
4.650
|
-
|
-
|
4.880
|
-
|
-
|
Cash Flow per Share
|
-
|
-0.2200
|
0.3000
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
45.9
|
242
|
326
|
-
|
162
|
265
|
266
|
Capex / Sales
|
-
|
0.63%
|
3%
|
3.32%
|
-
|
1.37%
|
2.01%
|
1.93%
|
Announcement Date
|
2/22/20
|
3/2/21
|
3/9/22
|
3/7/23
|
3/5/24
|
-
|
-
|
-
|
Last Close Price
2.65
BRL Average target price
3.89
BRL Spread / Average Target +46.79% Consensus |
1st Jan change
|
Capi.
|
---|
| -33.08% | 300M | | -30.56% | 11.21B | | -30.19% | 6.23B | | +7.42% | 6B | | -10.01% | 5.89B | | -0.73% | 4.72B | | +53.60% | 4.32B | | -9.42% | 3.77B | | -13.25% | 3.4B | | -5.84% | 3.03B |
Other Drug Retailers
|